• Home
  • Stock
  • Transgene Biotek Fundamental Analysis
  • Transgene Biotek Fundamental Analysis

Transgene Biotek fundamental analysis

TRABI

HealthcareSmall

3.94

0.08 (2.07%)
Last updated on 13 Nov, 2025 | 09:57 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Transgene Biotek Fundamentals

P/E Ratio

0

P/B Ratio

2.93

Div. Yield

0

Sector P/E

66.06

Sector P/B

-17.14

Sec. Div. Yield

2.19

  • Transgene Biotek Fundamentals is currently trading with a P/E Ratio of 0, compared to the sector average of 66.06. Its P/B Ratio stands at 2.93, while the sector’s is -17.14. In terms of returns, the stock offers a Dividend Yield of 0%, which is than the sector’s 2.19%.

Transgene Biotek Score Card

  • Price

    Attractive

  • Growth

    Good

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Transgene Biotek reflects: Price – Attractive, Growth – Good, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.